(PharmaNewsWire.Com, March 10, 2017 ) According to the report Global Cardiac Assist Device Market published by Market Data Forecast, the global market was worth $1312 million in 2015 and is projected to reach $1988.8 million with CAGR of 8.43% by 2020
On an average, the world encounters around 25 million cases of heart failure in a year. Cardiac Assist devices have been developed to overcome the scantiness of donors and meet the demand of organs. These are sort of mechanical pumps that work laterally with the heart to enhance its pumping efficiency and uphold the optimum blood flow throughout the body. These devices are used for the patients are less likely able to recover solely on medicines.
Various pipeline products are going through clinical trials in order to provide vigorous clinical data on the safety and efficacy of the devices. As new novel technologically, advanced products are being introduces this will further upsurge demand for cardiac assist devices in the near future.
With the increasing number of heart diseases, rise of geriatric population, unhealthy lifestyle, better technologies and constant work in creating new products the demand for these assisting devices has raised significantly. With the stressful lifestyle of younger generation causing heart problem at a younger age has increased the use of these devices which has also led to the growth of this market Furthermore; lack of donor hearts for transplantation is also driving the cardiac assist devices implantations in patients with severe heart complications, thereby increasing the market opportunities.
Segmentation • By Type • Ventricular Assist Device. • Right Ventricular Assist Device. • Left Ventricular Assist Device. • Bi-Ventricular Assist Device. • External Ventricular Assist Devices. • Intra-Aortic Balloon Pump. • Total Artificial Pump
• By Geography • Asia-Pacific • Europe • Latin America • Middle east-Africa • North America
Thoratec Corporation and Berlin Heart are the prominent players in the VAD segment whereas Teleflex and MAQUET are dominant players in the Intra-Aortic Balloon Pumps (IABP) segment. SynCardia is the foremost company to provide the only Food and Drug Administration (FDA) approved Total Artificial Heart (TAH).
Some other major players on the market include Teleflex Incorporated, Berlin Heart GmbH, Abiomed, Inc., HeartWare International, Jarvik Heart, Inc. and Terumo Corporation. BiVacor Pty Ltd, Braile Biomedica Ltd., Calon Cardio-Technology Ltd., CardiacAssist, Inc., CardioBridge GmbH, Carmat SAS, Cleveland Heart, Inc., CorAssist Cardiovascular Ltd., Evaheart Medical USA, Inc., Leviticus Cardio Ltd., MyoCardioCare, Inc., SynCardia Systems, Inc., Windmill Cardiovascular Systems, Inc.
The Global Cardiac Assist Devices Market study offers following deliverables: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped. • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics. • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis. • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development. • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment. • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies. • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions. • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout other related studies in the Medical Devices Segment:
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
